Thromboxane prostanoid receptor stimulation induces shedding of the transmembrane chemokine CX3CL1 yet enhances CX3CL1- dependent leukocyte adhesion

American Journal of Physiology - Cell Physiology

Volumn 298, Issue 6, 2010, Pages

  Tole, Soumitra ^a   Durkan, Anne M ^a   Huang, Yi Wei ^a   Ying Liu, Guang ^a   Leung, Alexander ^a   Jones, Laura L ^a   Taylor, Jasmine A ^a   Robinson, Lisa A ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Endothelial cells; Inflammation; Leukocytes

Indexed keywords

FRACTALKINE; PROSTANOID RECEPTOR; SIRNA 027; THROMBOXANE A2; THROMBOXANE PROSTANOID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN INTERACTION; VASCULAR ENDOTHELIUM;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADAM PROTEINS; CELL ADHESION; CELL MEMBRANE; CHEMOKINE CX3CL1; CHEMOTAXIS, LEUKOCYTE; DIPEPTIDES; DOWN-REGULATION; ENDOTHELIAL CELLS; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMANS; HYDROXAMIC ACIDS; K562 CELLS; LEUKOCYTES; PROTEASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION;

EID: 77952592312     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00380.2009     Document Type: Article

References (47)

1. 2 receptor in vivo. Circulation 101: 2833-2840, 2000.
2. 3C motif. Nature 385: 640-644, 1997.
3. Becker RC. Antithrombotic therapy after myocardial infarction. N Engl J Med 347: 1019-1022, 2002.
4. Chan JR, Hyduk SJ, Cybulsky MI. Detecting rapid and transient upregulation of leukocyte integrin affinity induced by chemokines and chemoattractants. J Immunol Methods 273: 43-52, 2003.
5. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296: 539-541, 2002. (Pubitemid 34408674)
6. Combadiere C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debre P, Tedgui A, Murphy PM, Mallat Z. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107: 1009-1016, 2003. (Pubitemid 36258725)
7. Diaz-Rodriguez E, Montero JC, Esparis-Ogando A, Yuste L, Pandiella A. Extracellular signal-related kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol Biol Cell 13: 2031-2044, 2002. (Pubitemid 34651490)
8. 3CL1 (fractalkine) in renal tubular epithelial cells. J Am Soc Nephrol 18: 74-83, 2007.
9. Fan H, Turck CW, Derynk R. Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide. J Biol Chem 278: 18617-18627, 2003. (Pubitemid 36799489)
10. 3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 188: 1413-1419, 1998.
11. i coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. J Pharmacol Exp Ther 296: 426-433, 2001.
12. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276: 37993-38001, 2001. (Pubitemid 37384050)
13. Ghilardi G, Biondi ML, Turri O, Guagnellini E, Scorza R. Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: a genetic risk factor. Stroke 35: 1276-1279, 2004. (Pubitemid 38697442)
14. Haller C, Kiessling F, Kubler W. Polarized expression of heterologous membrane proteins transfected in a human endothelial-derived cell line. Eur J Cell Biol 75: 353-361, 1997. (Pubitemid 28206297)
15. 2 receptor isoforms in human platelets. J Clin Invest 97: 949-956, 1996.
16. Hughes SE. Functional characterization of the spontaneously transformed human umbilical vein endothelial cell line ECV304: use in an in vitro model of angiogenesis. Exp Cell Res 225: 171-185, 1996.
17. 3CL1- mediated cell-cell adhesion. Blood 102: 1186-1195, 2003.
18. 3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521-530, 1997.
19. 2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells. Clin Exp Immunol 112: 464-470, 1998.
20. 2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells. Clin Exp Immunol 120: 71-78, 2000.
21. 2 signalling in humans: a "tail" of two receptors. Biochem Soc Trans 29: 641-654, 2001.
22. 2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest 114: 784-794, 2004.
23. Konopska JB, Watanabe SM, Witte ON. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37: 1035-1042, 1984.
24. 3CR1 -/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 111: 333-340, 2003.
25. 3CL1. J Biol Chem 280: 19858-19866, 2005.
26. 3CL1). Circulation 108: 2498-2504, 2003.
27. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1: 298-304, 2000.
28. 3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111: 1241-1250, 2003.
29. McDermott DH, Halcox JP, Schenke WH, Waclawiw MA, Merrell MN, Epstein N, Quyyumi AA, Murphy PM. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 89: 401-407, 2001. (Pubitemid 34132655)
30. 2 receptor-mediated activation of the mitogen activated protein kinase cascades in human uterine smooth muscle cells. Biochim Biophys Acta 1539: 147-162, 2001.
31. 2 for initiation of platelet-mediated contact sensitivity: dual activation of platelets and vascular endothelial cells. J Immunol 166: 617-623, 2001.
32. Moatti D, Faure S, Fumeron F, Amara MW, Seknadji P, McDermott DH, Debre P, Aumont MC, Murphy PM, de Prost D, Combadiere C. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk for coronary artery disease. Blood 97: 1925-1928, 2001.
33. Neame SJ, Uff CR, Sheikh H, Wheatley SC, Isacke CM. CD44 exhibits a cell type dependent interaction with triton X-100 insoluble, lipid rich, plasma membrane domains. J Cell Sci 108: 3127-3135, 1995.
34. 3CL1 in NK cytoskeleton organization and activation. Blood 112: 4420-4424, 2008.
35. 3CR1) in cardiac allograft rejection. J Immunol 165: 6067-6072, 2000.
36. Robinson LA, Tu L, Steeber DA, Preis O, Platt JL, Tedder TF. The role of adhesion molecules in human leukocyte attachment to porcine vascular endothelium: implications for xenotransplantation. J Immunol 161: 6931-6938, 1998. (Pubitemid 28562240)
37. 2 production in interleukin-1β-stimulated rat aortic smooth muscle cells. J Hypertens 20: 455-461, 2002.
38. Suzuki K, Ritchie K, Kajikawa E, Fujiwara T, Kusumi A. Rapid hop diffusion of a G-protein-coupled receptor in the plasma membrane as revealed by single-molecule techniques. Biophys J 88: 3659-3680, 2005. (Pubitemid 40586614)
39. Takahashi K, Sawasaki Y. Rare spontaneously transformed human endothelial cell line provides useful research tool. In Vitro Cell Dev Biol 28A: 380-382, 1992.
40. Teupser D, Pavlides S, Tan M, Gutierrez-Ramos JC, Kolbeck R, Breslow JL. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci USA 101: 17795-17800, 2004. (Pubitemid 40051966)
41. Thomas DW, Rocha PN, Nataraj C, Robinson LA, Spurney RF, Koller BH, Coffman TM. Proinflammatory actions of thromboxane receptors to enhance cellular immune responses. J Immunol 171: 6389-6395, 2003. (Pubitemid 37532066)
42. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 108: 15-23, 2001.
43. Tsou CL, Haskell CA, Charo IF. Tumor necrosis factor-α-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem 276: 44622-44626, 2001. (Pubitemid 37391240)
44. van Kerkhof P, Sachse M, Klumperman J, Strous GJ. Growth hormone receptor ubiquitination coincides with recruitment to clathrin-coated membrane domains. J Biol Chem 276: 3778-3784, 2001. (Pubitemid 37371453)
45. 3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc Pathol 11: 332-338, 2002.
46. Zahler S, Becker BF. Indirect enhancement of neutrophil activity and adhesion to cultured human umbilical vein endothelial cells by isoprostanes (iPF2α-III and iPE2-III). Prostaglandins Other Lipid Mediat 57: 319-331, 1999. (Pubitemid 29408683)
47. Zeiffer U, Schober A, Lietz M, Liehn EA, Erl W, Emans N, Tan Z, Weber C. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ Res 94: 776-784, 2004. (Pubitemid 38451739)